larotrectinib (vitrakvi) Report issue

Small molecule Orphan Drug FDA Approved FDA Accelerated Approval FDA Priority Review FDA
Back

Drug Pricing Summary

VA Big4

$105.5080 - $389.0022

VA FSS

$144.3200 - $541.2000

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
larotrectinib 100 mg (CAPSULE) $389.0022 VA Big4
  • VITRAKVI (60)
  • Bayer HealthCare Pharmaceuticals, Inc.
  • VITRAKVI (60)
  • Bayer HealthCare Pharmaceuticals, Inc.
    larotrectinib 100 mg (CAPSULE) $541.2000 VA FSS
  • VITRAKVI (60)
  • Bayer HealthCare Pharmaceuticals, Inc.
  • VITRAKVI (60)
  • Bayer HealthCare Pharmaceuticals, Inc.
    larotrectinib 20 mg / 1 mL (1 mL SOLUTION) $105.5080 VA Big4
  • VITRAKVI (100)
  • Bayer HealthCare Pharmaceuticals, Inc.
  • VITRAKVI (100)
  • Bayer HealthCare Pharmaceuticals, Inc.
    larotrectinib 20 mg / 1 mL (1 mL SOLUTION) $144.3200 VA FSS
  • VITRAKVI (100)
  • Bayer HealthCare Pharmaceuticals, Inc.
  • VITRAKVI (100)
  • Bayer HealthCare Pharmaceuticals, Inc.
    larotrectinib 25 mg (CAPSULE) $136.7955 VA Big4
  • VITRAKVI (60)
  • Bayer HealthCare Pharmaceuticals, Inc.
  • VITRAKVI (60)
  • Bayer HealthCare Pharmaceuticals, Inc.
    larotrectinib 25 mg (CAPSULE) $180.4000 VA FSS
  • VITRAKVI (60)
  • Bayer HealthCare Pharmaceuticals, Inc.
  • VITRAKVI (60)
  • Bayer HealthCare Pharmaceuticals, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue